Dedicated Development Teams engineering for Pharmaceuticals & Life Sciences
Production Dedicated Development Teams built for the compliance reality of Pharmaceuticals & Life Sciences. Not generic engineering adapted to your sector — sector-native architecture from the first design decision.
Pharmaceutical and life sciences Dedicated Development Teams deployments must satisfy FDA 21 CFR Part 11 alongside HIPAA when the systems touch electronic records used in FDA-regulated activities — clinical trial management, manufacturing execution, lab information systems. Part 11 requires validated systems: every Dedicated Development Teams application used in these contexts must be formally validated through IQ/OQ/PQ to demonstrate it consistently meets its specifications. This is not a documentation exercise — it requires the Dedicated Development Teams architecture to be designed for validation from day one.
The intersection of Part 11 and modern Dedicated Development Teams cloud deployments creates specific engineering obligations. When a Dedicated Development Teams application runs on cloud infrastructure, the system must demonstrate that the cloud provider's underlying infrastructure provides the audit trail, access controls, and data integrity controls Part 11 requires — or the application must implement these controls itself. Our teams architect pharma Dedicated Development Teams systems with this distinction resolved from the first infrastructure decision, not discovered during validation.
Pharmaceuticals & Life Sciences engineering operates under a specific set of regulatory frameworks that govern data handling, security controls, audit requirements, and system availability. Every Dedicated Development Teams architecture decision we make in this sector is evaluated against these frameworks — not added as a compliance layer afterward.
Computer System Validation planning before architecture is finalized — IQ/OQ/PQ traceability built into the design
Electronic signature and audit trail implementation in Dedicated Development Teams to satisfy Part 11 requirements
De-identification validation gates in data pipelines — PHI never reaches ML training infrastructure
Validation-ready documentation generated as a byproduct of the build process
Our Pharmaceuticals & Life Sciences case studies include Dedicated Development Teams technology deployed in production — compliant from architecture, delivered on fixed-price timelines. Not proof-of-concept work. Production systems serving regulated organizations.
View Case StudiesReady to deploy Dedicated Development Teams in your Pharmaceuticals & Life Sciences environment?
We deploy engineering teams that build Dedicated Development Teams systems compliant with FDA 21 CFR Part 11, HIPAA, SOC 2 from the first architecture decision. Fixed price. No discovery phase. Production delivery.
Start the Conversation